Lexaria Bioscience LEXX
-
-
-
已收盤:-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 0.95 | 98.62 | -0.07 | -1,574 | -2 | |
| 2025Q2 | 0.87 | 99.67 | -0.13 | -2,689 | -3 | |
| 2025Q1 | 1.71 | 98.94 | -0.21 | -3,750 | -4 | |
| 2024Q4 | 2.10 | 101.25 | -0.16 | -2,751 | -3 | |
| 2024Q3 | 3.05 | 99.41 | -0.16 | -2,691 | -3 | |
| 2024Q2 | 2.78 | 100.73 | -0.15 | -2,203 | -2 | |
| 2024Q1 | 3.63 | 98.09 | -0.14 | -1,743 | -2 | |
| 2023Q4 | 1.25 | 101.21 | -0.05 | -668 | -1 | |
| 2023Q3 | 1.00 | 96.12 | -0.13 | -1,139 | -1 | |
| 2023Q2 | 0.73 | 89.19 | -0.12 | -1,114 | -1 | |
| 2023Q1 | 2.72 | -0.37 | -2,444 | -2 | ||
| 2022Q4 | 2.46 | 99.55 | -0.22 | -1,324 | -1 | |
| 2022Q3 | 2.45 | 95.82 | -0.30 | -1,695 | -2 | |
| 2022Q2 | 2.98 | 49.47 | -0.24 | -749 | -2 | |
| 2022Q1 | 3.30 | -0.41 | -2,418 | -2 | ||
| 2021Q4 | 4.03 | -0.24 | -1,449 | -1 | ||
| 2021Q3 | 6.26 | -0.35 | -2,003 | -2 | ||
| 2021Q2 | 7.00 | -0.24 | -1,303 | -1 | ||
| 2021Q1 | 5.61 | 96.61 | -0.62 | -2,480 | -3 | |
| 2020Q4 | 224.37 | -260.29 | 0.15 | -1,088 | 0 |